These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 20859105)

  • 1. Countering side effects.
    Oldham J
    J Psychiatr Pract; 2010 Sep; 16(5):285. PubMed ID: 20859105
    [No Abstract]   [Full Text] [Related]  

  • 2. Can metformin or rosiglitazone reduce metabolic side effects associated with atypical antipsychotics?
    Housel AK; Waterbury N; Argo TR
    Issues Ment Health Nurs; 2009 Dec; 30(12):803-5. PubMed ID: 19916816
    [No Abstract]   [Full Text] [Related]  

  • 3. A randomized, double-blind, placebo-controlled trial of metformin treatment for weight gain associated with initiation of risperidone in children and adolescents.
    Arman S; Sadramely MR; Nadi M; Koleini N
    Saudi Med J; 2008 Aug; 29(8):1130-4. PubMed ID: 18690305
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic syndrome and mental illness. Weight gain and other unhealthy attributes increase risk of diabetes and heart disease.
    Harv Ment Health Lett; 2011 Aug; 28(2):5. PubMed ID: 21980633
    [No Abstract]   [Full Text] [Related]  

  • 5. The adjunctive use of metformin to treat or prevent atypical antipsychotic-induced weight gain: a review.
    Khan AY; Macaluso M; McHale RJ; Dahmen MM; Girrens K; Ali F
    J Psychiatr Pract; 2010 Sep; 16(5):289-96. PubMed ID: 20859106
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Management of atypical antipsychotic drug-induced weight gain: focus on metformin.
    Miller LJ
    Pharmacotherapy; 2009 Jun; 29(6):725-35. PubMed ID: 19476423
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of metformin for prevention of weight gain in psychiatric populations: a review.
    Newall H; Myles N; Ward PB; Samaras K; Shiers D; Curtis J
    Int Clin Psychopharmacol; 2012 Mar; 27(2):69-75. PubMed ID: 21979790
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Strategies to control antipsychotic-induced weight gain.
    Kapoor S
    Psychoneuroendocrinology; 2008 Sep; 33(8):1171. PubMed ID: 18650021
    [No Abstract]   [Full Text] [Related]  

  • 9. Metformin as a treatment for antipsychotic drug side effects: special focus on women with schizophrenia.
    Smith RC
    Am J Psychiatry; 2012 Aug; 169(8):774-6. PubMed ID: 22854925
    [No Abstract]   [Full Text] [Related]  

  • 10. Metformin in an Adolescent with Significant Weight Gain.
    Salau M; Adam B; Coffey BJ
    J Child Adolesc Psychopharmacol; 2015 Sep; 25(7):589-92. PubMed ID: 26375769
    [No Abstract]   [Full Text] [Related]  

  • 11. Use of metformin to control clozapine-associated weight gain in an adolescent with schizoaffective disorder.
    Weaver LA; De León DD; Borgmann-Winter K; Coffey BJ
    J Child Adolesc Psychopharmacol; 2010 Apr; 20(2):153-7. PubMed ID: 20415612
    [No Abstract]   [Full Text] [Related]  

  • 12. Antipsychotic-induced weight gain in patients with schizophrenia.
    Venkatasubramanian G
    JAMA; 2008 Apr; 299(16):1899; author reply 1899-900. PubMed ID: 18430906
    [No Abstract]   [Full Text] [Related]  

  • 13. [Biguanides].
    Suzuki T; Miwa T; Notoya Y; Odawara M
    Nihon Rinsho; 2006 Dec; 64 Suppl 9():627-32. PubMed ID: 17458294
    [No Abstract]   [Full Text] [Related]  

  • 14. [Drug treatment of insulin resistance].
    Tenoutasse S
    Rev Med Brux; 2009; 30(2):126-8. PubMed ID: 19517913
    [No Abstract]   [Full Text] [Related]  

  • 15. Diabetes control without weight gain.
    Health News; 1999 Apr; 5(5):6. PubMed ID: 10214130
    [No Abstract]   [Full Text] [Related]  

  • 16. Use of Metformin for Cardiometabolic Risks in Psychiatric Practice: Need-to-Know Safety Issues.
    Andrade C
    J Clin Psychiatry; 2016 Nov; 77(11):e1491-e1494. PubMed ID: 28076676
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metformin for Antipsychotic-Related Metabolic Syndrome in Children: Fact or Fiction?
    Naguy A; El-Sori D
    Chin Med J (Engl); 2018 Jun; 131(12):1490-1491. PubMed ID: 29893366
    [No Abstract]   [Full Text] [Related]  

  • 18. Considering metformin in cardiometabolic protection in psychosis.
    Curtis J; Newall H; Myles N; Shiers D; Samaras K
    Acta Psychiatr Scand; 2012 Oct; 126(4):302-3. PubMed ID: 22804349
    [No Abstract]   [Full Text] [Related]  

  • 19. When essential medications provoke new health problems: the metabolic effects of second-generation antipsychotics.
    Stein K
    J Am Diet Assoc; 2010 Jul; 110(7):992-1001. PubMed ID: 20630154
    [No Abstract]   [Full Text] [Related]  

  • 20. Antipsychotic-induced weight gain and metabolic abnormalities: implications for increased mortality in patients with schizophrenia.
    Casey DE; Haupt DW; Newcomer JW; Henderson DC; Sernyak MJ; Davidson M; Lindenmayer JP; Manoukian SV; Banerji MA; Lebovitz HE; Hennekens CH
    J Clin Psychiatry; 2004; 65 Suppl 7():4-18; quiz 19-20. PubMed ID: 15151456
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.